Skip to content

The effecf of soluble contrast esophageal visualization on the incidence of esophageal injury during radiofrequency ablation

The effecf of soluble contrast esophageal visualization on the incidence of esophageal injury during radiofrequency ablation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011487
Enrollment
Unknown
Registered
2017-05-25
Start date
2013-07-04
Completion date
Unknown
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

visulization group:contrast visulization
control group:regular ablation

Sponsors

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18-75 years old; 2. Sympotomatic proximal atrial fibrillation; 3. Ineffective for at least one antiarrhythmic drug; 4. The participant do sign informed consent.

Exclusion criteria

Exclusion criteria: 1. atrial fibrillation that could be corrected; 2. atrial fibrillation after cardiac surgery; 3. Previous history of left atrium ablation; 4. Confirmed atrial thrombus, tumor, or other disease that might interfere with catheter placement; 5. Allergy to antiarrhythmic drugs, anticoagulants, adenosine, or meglumine amines; 6. serious pulmonary disease; 7. Cardiac surgery, myocardial infarction, and coronary stenting were performed within 3 months; 8. Life expectancy is not more than 2 years; 9. Expected to have a heart transplant within 12 months; 10. Refused endosonography postoperatively; 11. Reflux esophagitis and other esophageal diseases; 12. long-term use of corticosteroids or immunosuppressive agents.

Design outcomes

Primary

MeasureTime frame
esophageal thermal injury incidence;

Contacts

Public ContactChen-yang Jiang

Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University

chenyangjiangmail@163.com+86 13857190051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026